Does Meritain Cover Wegovy? Here's Who Actually Decides

Affiliate disclosure: The RX Index may earn a commission if you use some of the provider links on this page. It never changes your price, and it never changes the coverage facts below. Read our full affiliate disclosure. Every insurance, government, and manufacturer detail here was checked on August 18, 2026.

By The RX Index Research Team | Last verified: August 18, 2026

Does Meritain cover Wegovy? There is no one Meritain-wide yes or no. Meritain Health is a third-party administrator — a company an employer can hire to run a health plan — not the company that creates one nationwide drug benefit for every Meritain member. On a self-funded plan, your employer sets the covered benefits and exclusions, Meritain administers the plan, and the pharmacy benefit manager applies the drug-list and prior-authorization rules. So your answer lives in your own plan documents and member system, not on a public “Meritain formulary.”

That's the part nobody tells you. And it's why you've spent 40 minutes looking for a "Meritain formulary" that doesn't exist.

Here's what does exist: three specific things that decide your answer, a way to find each one, and five price paths for Wegovy depending on which door you end up walking through. Cheapest is as little as $25 a month for an eligible person whose commercial plan already covers Wegovy. The manufacturer list price is $1,349.02 per package. Novo Nordisk's 2026 self-pay prices run from $149 to $399 a month, depending on the form and dose.

We also pulled two real 2026 employer benefit documents from employers that use Meritain. One says Wegovy is its preferred weight-loss medication. The other requires weight-loss GLP-1 prescriptions, including Wegovy, to be filled through the employer's in-house pharmacy. That comparison is further down, and it's the fastest way to understand why "does Meritain cover Wegovy" has no single yes-or-no answer.

This page is for you if:

• Your insurance card says Meritain
• You were prescribed Wegovy, or you're about to be
• You need to know if it's covered, what it'll cost, or what to do about a rejection

Read something else if:

• You only have Medicare — skip to the Medicare section, because the rules are completely different
• You're on Medicaid — you need your state's Medicaid drug list, not this page
• You're shopping compounded semaglutide — that's a different medication category under different rules. We cover it separately.
• You're trying to decide if Wegovy is right for your body — that's a conversation with a licensed clinician, not a website

What actually decides whether your Meritain plan covers Wegovy?

Everything on this page comes back to these three gates. All three have to clear in some form. If one fails, the plan does not pay the claim as submitted.

Ready to find your answer? Use the five-step check below. It tells you what to read, which number to call, and the exact questions to ask. → Jump to the Meritain Wegovy coverage check

The RX Index is an independent GLP-1 decision resource. We compare treatment paths on care, access, transparency, and cost. See how our research works.

First, the honest part

We cannot tell you whether your plan covers Wegovy. Neither can Meritain's public website. Your plan documents hold that rule, and many employers do not publish the full rulebook openly.

It gets worse before it gets better. Even a real Aetna drug list won't settle it. We checked the July 1, 2026 edition of the Aetna Standard Plan drug guide, and it lists Wegovy tablets, standard pens, and Wegovy HD as preferred brand products. Feels like a green light, right? It isn't. Aetna's own guide says coverage varies by plan, plan documents control, and some plans may not cover drugs used for weight loss.

So if you came here hoping we'd say, “Yes, Meritain covers Wegovy if your BMI is 30,” that answer would be made up without your plan's written rule. Meritain does not publish one universal Wegovy BMI cutoff. A page that gives you one without seeing your plan is guessing.

Here's what we did instead of guessing.

We pulled real employer benefit documents from employers that use Meritain. We wrote out the exact words to say when someone finally picks up the phone. We built a rejection decoder so you can tell a paperwork problem from a true exclusion. And we mapped the current manufacturer prices in order, cheapest first.

Three manufacturer self-pay paths below do not need your plan to approve the drug at all.

Does Meritain cover Wegovy?

Meritain does not set one universal Wegovy benefit for every member. Meritain describes itself as a national third-party administrator. On a self-funded employer plan, the plan sponsor sets the benefits and exclusions, Meritain administers the plan, and the pharmacy benefit manager handles the drug list, prior authorization, and pharmacy rules chosen for that plan.

Picture a chain with four links. Money and rules flow down it, and your prescription flows up it.

1. Your employer or plan sponsor. Sets the benefit design and exclusions. On a self-funded plan, it pays covered claims with plan funds.
2. Meritain. Runs the plan under those documents. Handles member service and claims administration.
3. The pharmacy benefit manager (PBM). Manages the drug side — the drug list, prior authorizations, quantity limits, and pharmacy network. Sometimes this is CVS Caremark. Sometimes it is someone else entirely.
4. Your pharmacy. Runs the claim and tells you yes, no, or “that'll be $1,349.02.”

When you call Meritain and ask if Wegovy is covered, you're asking the referee what the rules of the game are. The referee can read you the rulebook. The referee did not create one universal rule for every employer.

That's not a dodge. It's the single most useful fact on this page, because it tells you where to actually look.

Wait — is Meritain even an insurance company?

Meritain is a third-party administrator, not a single insurance policy. Meritain says it has more than 40 years in the business and calls itself “a national third party administrator (TPA).” Meritain is an Aetna company, and Aetna is part of CVS Health. That structure is why your card may carry more than one name, and why there is no single public “Meritain formulary” that applies to every member.

This one table clears up most of the confusion people arrive with.

And here's Meritain telling employers the exact thing we've been telling you. When Meritain markets its pharmacy program, it says it focuses on formulary control, biosimilar and generic-first strategies, and “a range of GLP-1 plan designs.”

Read that last phrase again. A range of plan designs. That's a menu. Employers choose a design. Which means there is no one Meritain answer sitting out there waiting to be found — there are many plan-specific answers.

Meritain also says its pharmacy program gets pricing “through our relationship with CVS Health.” Useful clue, but only a clue. Your card and plan documents still control.

Why do two people with Meritain cards get different answers?

Because they can work for different employers with different plan documents. In a self-funded plan, the employer or plan sponsor takes direct financial responsibility for covered claims and hires an administrator to run the plan. The sponsor can choose a benefit design that covers weight-loss drugs, restricts them, or excludes them.

“Self-funded” sounds like jargon. It's simple. Your employer is the bank. Meritain is the cashier. The cashier follows the bank's policy.

This is not rare. In KFF's 2025 Employer Health Benefits Survey, 80% of covered workers at firms with 200 or more workers were in self-funded plans, compared with 27% at smaller firms.

But it means your coworker's approval, a stranger's post, and a public Aetna drug list are all evidence — none of them are your answer.

Employer GLP-1 decisions usually land in one of three shapes:

• Diabetes-only or indication-limited coverage. The plan may pay for one drug or use but not Wegovy for weight management.
• Covered for weight management, with rules. Prior authorization, a plan-specific BMI rule, a weight-management program, step therapy, or a restricted pharmacy.
• Excluded completely. The plan document says weight-loss drugs or services are not a covered benefit.

If you want the general version of this check for any insurer, use our full walkthrough on how to get insurance to cover a GLP-1. This page stays focused on Meritain specifically.

What do real Meritain employer plans say about Wegovy?

Two employers that use Meritain published 2026 benefit materials with different GLP-1 rules. South Orange & Maplewood says Wegovy is its preferred weight-loss medication. Centra says weight-loss GLP-1 prescriptions, including Wegovy, must be filled through Centra's in-house pharmacy. Neither rule came from one universal Meritain formulary, and neither rule tells you what your employer bought.

We went looking for employer benefit documents that employers had posted publicly. Here is what the documents actually say — and no more than they say.

Both sources were checked on August 18, 2026.

Sit with that for a second. Same administrator. Same plan year. Two employers.

One employee sees Wegovy named as the preferred weight-loss medication. The other may have the benefit but hits a pharmacy fence: filling it outside the required in-house pharmacy can stop the claim. Two people can both say “Wegovy is covered” and still have radically different experiences at the counter.

The South Orange document handed us two more things worth knowing. It says Meritain is an Aetna company and that the plan uses the Aetna Choice POS II network. It also tells members that prior approvals under the former NJ SEHBP arrangement will not carry over to Meritain. That is a transition rule for that employer, not a universal Wegovy rule, but it answers a question many people do not know to ask.

How to find your own employer's document

This is the method we used.

1. Search: "[your employer's name]" benefits guide 2026 filetype:pdf
2. No luck? Go straight to your employer's HR or benefits page and look for the open-enrollment guide.
3. Open it and press Ctrl-F or Command-F. Search three terms, in this order: GLP-1, then Wegovy, then weight loss.
4. Still nothing? Ask for the Summary Plan Description, prescription drug list, exclusions, and any pharmacy-benefit or plan-change notices.
5. If your private-employer plan is covered by ERISA, send the request in writing. U.S. Department of Labor guidance says the plan administrator generally must provide the Summary Plan Description and certain plan documents after a proper written request. Public-employer and other non-ERISA plans can follow different rules.

When this search works, you're reading the actual rule instead of a stranger's guess about it.

How do I check if my Meritain plan covers Wegovy?

Check your own plan documents and member portal rather than a public drug list. Identify who runs the pharmacy side of your card, search your member-specific drug list for your exact Wegovy product, then ask three questions: is the prescribed use a covered benefit, is prior authorization or another rule required, and what will I owe at the counter?

Five steps. Most of the work is reading the card and asking the right question.

Step 1 — Read your card, both sides. You're looking for the member-services number, a separate pharmacy or prescription number, the Rx BIN, RxPCN, and RxGRP codes if they're printed, and your employer or group name. If a second name shows up on the pharmacy side — Caremark, Optum Rx, Express Scripts, or another company — that is your PBM, and that is usually the first place to check a Wegovy prescription benefit.

Step 2 — Find your plan documents. Look for the Summary Plan Description, Summary of Benefits and Coverage, prescription drug list, exclusions section, pharmacy-benefit guide, and mid-year change notices. Your employer's HR portal or benefits site is where these often live.

Step 3 — Search the exact product, not just the ingredient. This matters more than people expect. Search “Wegovy 2.4 mg pen” or “Wegovy 4 mg tablet,” not only “semaglutide.” Plans can treat brands, forms, strengths, and prescribed uses as separate items.

Step 4 — Make the call. Use the pharmacy number on your card first. If your card only has one number, Meritain's general member-services line is 1-888-324-5789, open 7:00 a.m. to 6:30 p.m. Central. Meritain says the number on the back of your card is faster; the general line may transfer you.

Here's your script. Read it out loud if you want — it works better when you sound like you know what you're asking for.

“Hi. I'm on a plan administered by Meritain, and I need to check coverage for the exact product on my prescription. 1. Is this exact form and dose on my drug list? 2. Is the prescribed use a covered benefit under my plan? 3. Is weight-loss medication excluded anywhere in the plan? 4. Is prior authorization required? 5. Can you send me the written prior-authorization criteria used for my plan? 6. Is step therapy, a weight-management program, or a restricted pharmacy required first? 7. What will I owe after my deductible, copay, or coinsurance? 8. What is the appeal or exception process if it is denied?”

Step 5 — Write it all down. The representative's name. The date and time. The reference number. The exact words used. The name and date of any policy quoted. If you end up appealing later, this log is the most valuable thing you own.

And ask for it in writing. “Can you send that to me in my portal or by mail?” costs you nothing and changes everything if the story shifts in two months.

Do not stop at “Wegovy is covered.” Get the exact form, dose, use, approval rule, pharmacy rule, and processed price. That is the difference between a real answer and another phone call.

The right GLP-1 provider isn't the same for everyone — it depends on your state, insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred treatment path, and your budget. Once you know what your plan will do, use The RX Index's Find My GLP-1 Path tool for a personalized path in about two minutes.

Wegovy is on an Aetna drug list. Doesn't that mean I'm covered?

No. The July 1, 2026 Aetna Standard Plan drug guide lists Wegovy tablets, standard pens, and Wegovy HD as preferred brand products, but the same guide says coverage varies by plan and that plan exclusions and limitations govern. It also warns that some plans may not cover drugs used for weight loss. A public drug list is a clue, not a coverage decision.

This trips up more people than any other single thing, so let's separate four ideas that look identical and aren't.

• On the drug list. The drug appears on a formulary. That's it.
• A covered benefit. Your plan actually pays for that category and prescribed use.
• Prior authorization. The plan wants proof before it pays.
• Cost sharing. What you owe after the other gates clear.

You can pass the first test and fail the second. That's exactly what happens when a drug appears in a broad guide but the employer's plan excludes weight-loss medication: the drug is right there on the list, and the claim still bounces.

Here's the Aetna example, labeled honestly:

This is one public Aetna Standard Plan drug guide. It is not your plan's drug list, and it does not establish your coverage.

Nine reasons a listed drug can still reject at the counter:

1. Your plan excludes weight-loss medication or the prescribed use
2. The prescription is for a use the plan does not cover
3. Prior authorization has not been submitted
4. Prior authorization was submitted but did not meet the plan's criteria
5. The wrong form, strength, or product was submitted
6. A quantity limit was hit
7. The pharmacy is out of network or not the required specialty or in-house pharmacy
8. Your deductible is not met, so you owe the full negotiated price
9. The plan year rolled over and the drug list or rule changed

Several of those are fixable. The exact rejection message tells you whether you have a paperwork problem wearing a scary costume or a real benefit exclusion.

Does Meritain use CVS Caremark for prescriptions?

Often, but not always. Meritain offers employers a pharmacy program through its relationship with CVS Health, and some Meritain plans use CVS Caremark. An employer can also use another PBM or separate the pharmacy benefit from the medical administrator, so check the pharmacy side of your card before calling anyone.

This is why we keep saying “check your card” instead of just handing you one phone number.

If your card says Caremark, use your member portal and the plan-specific policy tied to your group. A public CVS Caremark policy can show you what a rule may look like, but it may not be your rule. We break down the moving parts in what GLP-1s CVS Caremark covers.

If your card shows a different pharmacy company, that company's rules apply instead, and a Caremark policy is irrelevant to your claim.

One live example from our employer register: South Orange & Maplewood says its 2026 prescription coverage moved to CVS Caremark. Centra's guide points members to its own in-house pharmacy for weight-loss GLP-1 fills. Same medical administrator, different pharmacy path. That's the whole point.

Does Meritain cover the Wegovy pill, the pen, and Wegovy HD the same way?

Not necessarily. The current Wegovy prescribing information lists a daily tablet in 1.5 mg, 4 mg, 9 mg, and 25 mg strengths; weekly standard pens from 0.25 mg through 2.4 mg; and Wegovy HD at 7.2 mg. A plan can assign different drug-list status, prior-authorization rules, quantity limits, or prices to each one. Your prescription, drug-list search, and prior-authorization request all need to name the same exact product.

Getting this wrong wastes weeks. Someone confirms “Wegovy is covered,” the doctor sends in the tablet, and the claim rejects — because the plan covered the standard pen.

Say this on the phone, word for word:

“Please check the complete product name, form, and dose from my prescription. I don't want a general answer for Wegovy or for semaglutide.”

Small sentence. Saves an enormous amount of time.

Does Meritain require prior authorization for Wegovy?

There is no universal Meritain Wegovy prior-authorization rule. The requirement comes from your plan and pharmacy benefit manager. Ask for the exact written criteria used for your plan before your prescriber submits anything, because using the wrong rule can cause an avoidable denial or delay.

Prior authorization means the plan wants proof before it pays. That's all.

To show you what these rules can look like, here's a real one from Aetna's published 2026 non-Medicare weight-loss policy. This is an example, not your rule. Its adult weight-management pathway includes:

• Age 18 or older
• A starting BMI of 35 or higher
• Participation in a comprehensive weight-management program for at least six months before drug therapy
• Use with a reduced-calorie diet and increased physical activity

To continue coverage for Wegovy under that policy, the member must have completed at least three months at a stable maintenance dose and have lost at least 5% of baseline body weight or maintained that loss.

Two things to take from that. First, plan rules can be stricter than the FDA label. FDA approval says a product may be legally marketed for an approved use; it does not force an employer plan to pay for it. Second, six months of documented program participation is not something you can produce on a Tuesday afternoon. If your plan requires it, you want to know that now, not after a denial.

What your prescriber may need on hand:

• The exact product, form, strength, and dose
• The prescribed use
• Current weight and BMI, if your plan's criteria use them
• Starting weight and BMI, if renewal rules use them
• Diagnosis documentation
• Previous treatments tried
• Weight-management program records, if required
• Current and past medications
• Labs or specialist records the policy asks for
• Step-therapy history
• Follow-up measurements and the renewal deadline

Not every plan wants all of it. Get the written criteria and you'll know exactly which ones apply to you.

One thing changed on August 15, 2026

Meritain moved its medical-management prior-authorization portal to Availity. Meritain announced on August 7, 2026 that, starting August 15, 2026, requests would no longer be accepted through meritain.mednecessity.com. That address now redirects users to Availity, and provider offices can register through Availity Essentials.

There's a second detail in that notice worth reading twice: appeals are not supported through this update. Providers are told to follow the instructions in the applicable non-certification determination letter.

Important, and most people get this backwards: Meritain describes this as a change for medical management programs. A self-administered Wegovy prescription is normally handled under the pharmacy benefit through your PBM. So for most readers, the Availity change does not replace the pharmacy prior-authorization route printed on the card. It is here because a doctor's office using the old Meritain medical portal for another request now needs the current route.

Your next move: copy the document list above and send it to your prescriber's office. If a request has already failed, do not submit the same packet again. Jump to the denial decoder and find the exact problem first.

Why was my Wegovy denied?

Different rejection messages require completely different responses. A missing prior authorization, failed criteria, a non-formulary product, an outright benefit exclusion, a quantity limit, and an unmet deductible are separate problems. Treating all of them as “appeal it” wastes weeks. Get the exact rejection language in writing first.

This is our decoder. Find your message in the left column and you'll know who has to act next.

Four words people use interchangeably that mean different things:

• Rejection — the pharmacy claim did not process as submitted
• Denial — the plan or PBM reviewed a request and said no
• Exclusion — the plan document does not cover that benefit or category
• High cost — the claim may have worked, but your share is large

Knowing which one you're holding tells you whether you need a correction, an appeal, an HR conversation, or a different price path.

One line we won't cross, and neither should you: don't change or relabel a diagnosis to get coverage. Any prior authorization or appeal has to accurately reflect what your clinician actually diagnosed and prescribed. It's the wrong thing to do, and it puts the prescriber and claim at risk.

Can I appeal a Meritain Wegovy denial?

Yes. A public New York case shows a Wegovy denial on a self-funded plan administered on the pharmacy side by CVS Caremark being overturned. But your denial notice controls the route and deadline, and an appeal generally cannot create a benefit that your plan expressly excludes. For ERISA-covered plans, federal rules generally require at least 180 days to request review after an adverse benefit determination.

There are three tracks. Pick the right one and you'll save time.

Track 1 — Something was missing or wrong. BMI or starting weight not documented. Program history left out. Wrong form submitted. Records not attached. A question the prescriber did not answer.

Fix it and ask whether the plan accepts a corrected or new submission. Do not build a giant appeal for a missing checkbox if the PBM will accept a corrected request.

Track 2 — You disagree with the criteria decision. This is what appeals are for: an internal appeal, a letter from your prescriber, the records that answer the failed criterion, and a request for any available exception. If your plan offers external review after its internal steps, follow the notice to that next rung.

Track 3 — It's a flat exclusion. A medical-necessity letter normally cannot override contract language that excludes weight-loss drugs. Before you spend two weeks writing one, find out which kind of “no” you got. Then:

• Ask HR or your benefits team whether any exception or plan-amendment process exists
• Request the exact exclusion language in writing
• Ask when the next plan year or open-enrollment period begins
• Compare the manufacturer cash prices further down this page

On deadlines: use the date and instructions in your denial letter. ERISA's 180-day appeal rule does not make every plan or every review route identical, and special rules can apply to urgent or concurrent-care claims. Meritain's August 2026 Availity notice also says that its portal update does not handle appeals; providers must follow the applicable denial letter.

One appeal that worked, on the record

Most pages give you a made-up success story here. We'd rather give you a public government record.

New York's Department of Financial Services publishes external-appeal outcomes. In case 202208-152420, a patient on a self-funded plan, with the pharmacy benefit listed as CVS Caremark, was denied continued Wegovy coverage. The plan's continuation rule required at least a 5% weight reduction from starting weight. The patient had gone from 174 pounds to 141 pounds. The independent reviewer overturned the denial.

One case isn't a promise, and New York's public appeal route does not tell you which rights your own plan or state provides. This is a record about the appeal process — not evidence about how Wegovy will work for anyone. But it shows two things worth carrying with you. A self-funded denial can be reversed. And the strongest appeal answers the plan's exact written rule using the plan's own numbers.

That's why the very first thing you ask for is the criterion in writing.

Your appeal packet checklist:

• The denial notice itself
• The appeal deadline from that notice
• Member and claim or request ID numbers
• The exact prescription
• The specific criterion you're challenging
• Supporting medical records
• Your prescriber's written explanation
• Treatment and program history
• A clear statement of what you want the plan to approve
• Proof of submission
• Your call log with reference numbers

My old plan already approved Wegovy. Does that carry over to Meritain?

Do not assume it carries over. The South Orange & Maplewood 2026 transition FAQ says prior approvals under its former NJ SEHBP arrangement would not carry over to Meritain. That is one employer's rule, not a universal Meritain policy. Ask the new PBM whether your Wegovy authorization transfers, must be renewed, or must be filed again.

Short section, big save.

Nobody expects this one. You got approved under the old setup, your employer changes administrators, and you find out at the pharmacy counter with only a few doses left.

Check your refill date now. Ask the new PBM and your prescriber to start the required process as soon as the new plan allows. If a gap may happen, ask the clinician what to do; do not guess about restarting, changing a dose, or extending the time between doses.

How much does Wegovy cost with Meritain?

There is no single Meritain price for Wegovy. Your cost depends on whether your exact product and prescribed use are covered, its tier, your remaining deductible, your copay or coinsurance, the required pharmacy, and whether you qualify for Novo Nordisk's savings offer. Wegovy's current manufacturer list price is $1,349.02 per package, while Novo Nordisk's 2026 self-pay prices run from $149 to $399 per month depending on the form and dose.

Here's the whole ladder, cheapest first. All manufacturer prices and offer dates below were checked through NovoCare on August 18, 2026.

Five questions get you your real number:

1. Is my exact product and prescribed use covered?
2. What tier is it on?
3. Have I met my deductible?
4. Is my share a flat copay or a percentage?
5. Can the manufacturer savings offer apply to the processed claim?

The $25 path — and why we're telling you about it first

If your plan covers Wegovy, Novo Nordisk's savings offer can bring an eligible patient to as little as $25 a month, with savings capped at $100 a month. An employer plan is commercial coverage, but the offer's full eligibility terms still control.

Straight talk: we make nothing if you take this path. It's still the right one. If your plan covers the drug and you have a prescriber you like, check the savings-offer terms before paying for another service.

One caution, because “as little as $25” gets misread constantly: with a $100 monthly savings cap, if your plan leaves you owing $400, the card can reduce that to $300 — not $25. The $25 figure works only when the plan and savings offer together reduce the amount that far. Confirm the processed price at the pharmacy before you build a budget around it.

Why your price is high even though you're “covered”

• Your deductible is not met, so you owe the negotiated price
• Your share is coinsurance, not a flat copay
• The product sits on a non-preferred tier under your plan
• The pharmacy is out of network or not the required pharmacy
• The savings offer was not applied
• You do not meet the offer's eligibility terms
• The wrong form, strength, quantity, or timing was submitted

Those are cost or claim-processing problems, not all coverage denials. Different problem, different fix — usually a claim review or phone call before an appeal.

What if I'd rather have someone handle the insurance part for me?

Ro offers a free insurance checker for the Wegovy pen, and its paid weight-loss program includes insurance-concierge support for members. Ro says the checker contacts the plan and returns a personalized report about coverage, prior authorization, and available cost information. It is useful for the pen. It is not a universal Wegovy checker.

Let's be precise about what this is and isn't, because the honest version converts better than the hyped one.

What Ro's free checker does: it uses information from your insurance card, contacts your plan, and sends a report. You do not need a paid Ro membership to run the checker.

What it doesn't do — as of August 18, 2026: it does not check coverage for the Wegovy pill, the Foundayo pill, or the Zepbound KwikPen. If your prescription is for the Wegovy tablet, the checker will not answer your question. Call your PBM using the script above instead — that's free too, and it is the right tool for that product.

Ro Body pricing: $39 for the first month, then $74 to $149 per month depending on the membership term. The $74 rate is the 12-month plan prepaid annually; the standard monthly plan is $149. That fee is on top of the medication cost. Nobody should be surprised by that at checkout.

Who should skip this entirely: if your plan already covers Wegovy, your prescriber is handling the paperwork, and you do not need ongoing telehealth care, you may not need a membership. The manufacturer savings path can be cheaper, and we earn nothing from it. What a program buys you is care plus help doing the follow-up work — which is worth real money to some people and worth nothing to others. You know which one you are.

Why there are no compounded providers in this decision section: you searched for Wegovy. Wegovy is an FDA-approved medication made by Novo Nordisk. Compounded semaglutide is a different product category. It is not Wegovy, not an FDA-approved generic version of Wegovy, and not an automatic substitute. FDA does not approve compounded drugs or verify their safety, effectiveness, or quality before they are marketed. Putting a compounded product in front of you as though it answered the same coverage question would be answering a question you did not ask.

Affiliate link — Ro option. If your prescription is for the Wegovy pen and you'd rather not make the first coverage call yourself, Ro's checker can contact your plan and send a report. The checker is free; a paid membership is separate. → Check Wegovy pen coverage with Ro If your prescription is for the tablet, use the call script above instead. It'll get you a better answer.

Does Medicare change the answer?

Yes, if you also have Medicare Part D. The Medicare GLP-1 Bridge is a separate CMS program running from July 1, 2026 through December 31, 2027. It gives eligible Part D beneficiaries access to all Wegovy formulations for a flat $50 copay per monthly supply when the drug is prescribed through the Bridge for weight management.

This program is genuinely different from anything else on this page, and a lot of people who qualify do not know it exists.

How it works: the prescriber sends the prescription to the pharmacy first. The pharmacy runs the claim through the Medicare GLP-1 Bridge. When prior authorization is required, the pharmacy normally sends the request to the prescriber electronically or by fax within 24 to 72 hours. The prescriber then submits the Bridge prior authorization. CMS says a decision is sent within 72 hours after submission.

Do not send the prior authorization before the pharmacy claim creates the Bridge record. CMS says that can return a “patient not found” error.

What it costs: $50 per monthly supply. The Part D deductible does not apply. The $50 does not count toward Part D true out-of-pocket costs, and the low-income subsidy does not reduce it.

The catches, and they matter:

• The Bridge operates outside the normal Part D payment flow
• The $50 does not count toward your Part D deductible or true out-of-pocket total
• Extra Help or the low-income subsidy does not reduce the $50
• Manufacturer coupons cannot be used to push the Bridge copay below $50
• The program is scheduled to end December 31, 2027
• The prescription must be for reducing excess body weight and maintaining weight reduction; a prescription for a Part D-covered indication uses the Part D route instead
• CMS routes people using a GLP-1 for type 2 diabetes, moderate-to-severe obstructive sleep apnea, or noncirrhotic MASH outside the Bridge; that does not make all three approved Wegovy uses
• A Wegovy prescription for cardiovascular risk reduction should be routed to the Part D plan
• Some plan types are not eligible, including private fee-for-service plans, certain cost and prepayment plans, PACE, fallback plans, and religious fraternal benefit plans unless the person also has an eligible standalone Part D plan
• There is no Bridge appeal process. A prescriber can resubmit if information was wrong, updated, or missing.

The clinical criteria are checked at the time GLP-1 therapy began. The person must be at least 18 and meet one of these three paths:

1. BMI of 35 or higher, or
2. BMI of 30 or higher with heart failure with preserved ejection fraction, uncontrolled hypertension under CMS's definition, or chronic kidney disease stage 3a or above, or
3. BMI of 27 or higher with prediabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease

The prescriber attests that the drug is for weight management with ongoing lifestyle changes and that the person met the applicable criterion when therapy started.

And the thing to be clear about: the Bridge has nothing to do with whether your Meritain employer plan covers Wegovy. It's a separate federal program with its own door. If you have both an employer plan and Part D, they are two different questions with two different answers.

Use our Medicare GLP-1 Bridge eligibility guide to check the three clinical paths, or the Bridge application-process guide for the pharmacy-first workflow.

What if my plan just won't cover Wegovy at all?

Match your response to the actual reason. An incomplete prior authorization can be corrected. A non-formulary product may have an exception route. A flat employer exclusion is an HR and cash-price decision. All three give you a next step, but they are not the same next step.

If the prior authorization was incomplete: get the written criteria, fix what was missing, use the required submission route, and track the reference number. Do not keep resending the same incomplete packet.

If your exact form isn't on the list: ask four questions. Is a different Wegovy form covered? Is a formulary exception available? Which weight-management drugs are covered? Would changing forms require a new prescription? Then take those answers to your prescriber — a form change is a clinical decision, not a billing one.

If weight-loss medication is flat-out excluded: this is the hardest version, so here's the honest map.

• Ask HR or your benefits team whether any exception exists and when the next benefit-design or open-enrollment decision will be made
• Request the exact exclusion language in writing so you know what you're dealing with
• Look hard at the cash prices above. $149 a month for the 1.5 mg tablet is a very different conversation from $1,349.02, and a lot of people give up before they learn the current manufacturer price exists
• Ask whether another FDA-approved product or covered indication is relevant to the clinician's actual diagnosis; do not relabel a diagnosis for coverage
• Remember that self-pay purchases outside insurance do not count toward the plan deductible or out-of-pocket limit

Wegovy vs. compounded semaglutide — not the same thing. Wegovy is an FDA-approved branded medication. A compounded semaglutide product is not Wegovy, is not an FDA-approved generic version of it, and is not an automatic substitute. Compounded drugs are not FDA-approved, and FDA does not verify their safety, effectiveness, or quality before marketing. They sit under different federal rules and need their own clearly labeled decision path.

Still weighing your options? The RX Index's Find My GLP-1 Path tool asks about your state, insurance situation, FDA-approved or compounded preference, injection or oral preference, and budget — then shows the paths that fit. → Find My GLP-1 Path

Who this page can't help

We'd rather send you to the right place than keep you on the wrong one.

• Medicare or Medicaid only? The employer-plan rules on this page do not apply to Medicaid, and Medicare has its own routes. Start with our Medicare GLP-1 Bridge eligibility guide or your state Medicaid drug list.
• Looking at Zepbound instead of Wegovy? Different drug, maker, forms, cash prices, and coverage rules. See our guide to Zepbound providers that accept insurance.
• Trying to figure out if Wegovy is medically right for you? That's a clinician conversation. Nothing on this page is medical advice, and coverage has nothing to do with whether a medication suits your body.
• Your plan excludes weight-loss drugs and cash-pay isn't realistic right now? That's a real answer, and it's not a failure. Ask HR when the next plan-design decision happens and keep the written exclusion for your records.

How did we verify this page?

We checked the claims on this page against named primary sources: Meritain's own website and August 2026 notice, employer-posted benefit documents, Aetna's 2026 formulary and prior-authorization policy, Novo Nordisk's current price guide and prescribing information, CMS Bridge materials, Department of Labor appeal guidance, FDA compounding guidance, and a New York public appeal decision. These sources can tell you how the systems work. They cannot reveal your private plan without your member-specific documents.

What we verified — August 18, 2026:

What we did not verify, and can't from the open web:

• Your employer's exact pharmacy benefit
• Your member-specific drug list
• Your deductible balance
• Your copay or coinsurance
• Whether your prior authorization will be approved
• Whether Wegovy is appropriate for you

Who wrote this and why: The RX Index Research Team. We read Meritain's own published material, pulled named employer documents, checked the current manufacturer price guide, and traced the Medicare workflow through CMS. We did it because a page that treats Meritain like one nationwide insurance policy gives you the wrong mental model from the first sentence. We did not access your plan. There's no medical reviewer on this page because this page explains coverage and process, not medical treatment.

Corrections: if something here is wrong or out of date, tell us and we'll fix it with a dated note. We don't quietly delete mistakes. Read our corrections policy.

What are the quick answers about Meritain and Wegovy?

Is Meritain the same as Aetna? No. Meritain Health is an Aetna company, and Aetna is part of CVS Health. Meritain administers benefits under plan-specific documents. An Aetna network, drug list, or policy may be relevant to your arrangement, but it does not automatically establish your Wegovy coverage.

Why can't I find a Meritain formulary? Because there is no single public list that applies to every Meritain member. The drug list comes from the pharmacy benefit selected for your plan. Search your own member portal and card, not just the open web.

Does every Meritain plan use CVS Caremark? No. Meritain has a pharmacy relationship with CVS Health, and some employers use CVS Caremark. Others use a different PBM or a separate pharmacy arrangement. The pharmacy side of your card tells you where to start.

Does Meritain cover Wegovy for weight loss? Some employer plans do, some attach rules, and some exclude weight-loss medication. South Orange & Maplewood's 2026 plan says it covers weight-loss GLP-1s and prefers Wegovy. That proves coverage can exist under a Meritain-administered plan; it does not prove yours has it.

Does Meritain cover semaglutide? That question is too broad to answer safely. Wegovy, Ozempic, and compounded semaglutide products are not one coverage category. Check the exact product, form, strength, and prescribed use.

Does Meritain cover the Wegovy pill? Possibly, but a general “Wegovy is covered” answer doesn't settle it. Search for the exact tablet strength and ask whether its authorization rules differ from the standard pen.

Does Meritain cover Wegovy HD? Check it as its own 7.2 mg product. Approval for a standard Wegovy pen does not automatically establish HD coverage.

What does “preferred” mean? It means the product has favorable status within the source's drug list or benefit design. It does not automatically mean no prior authorization, no deductible, or a low copay. South Orange calls Wegovy preferred; the public Aetna guide labels the Wegovy products preferred brand. Your own plan still sets the final rule and price.

Who do I call — Meritain or CVS Caremark? Start with the pharmacy number on your card for a self-administered Wegovy prescription. If your card only lists one number, Meritain's general line is 1-888-324-5789, open 7:00 a.m. to 6:30 p.m. Central. Expect a possible transfer.

What's a self-funded plan? It is a plan where the employer or plan sponsor takes direct financial responsibility for covered claims and hires an administrator such as Meritain to run the plan. The sponsor sets the benefit design under the plan documents.

Can my employer decide not to cover Wegovy? A self-funded plan can exclude weight-loss drugs or limit the covered uses, subject to the laws and plan rules that apply. That is why the exclusions section and HR benefit team matter.

How long does a Wegovy prior authorization take? There is no single Meritain timeline for every pharmacy request. Ask the PBM when it received a complete request, when a decision is due, and how urgent requests are handled. Do not count time from the day the prescription was written if the PA was never submitted.

Does Meritain cover Wegovy for cardiovascular risk reduction or MASH? The prescribed use changes the policy that may apply. Current Wegovy labeling includes cardiovascular risk reduction for both the injection and tablets in eligible adults, while the MASH indication applies to the injection and not the tablets. Ask about the exact approved use on the prescription and the plan-specific criteria for it.

Does Wegovy treat sleep apnea? Wegovy's current label does not list obstructive sleep apnea as an approved indication. Do not confuse Wegovy with another GLP-1 product that may have a sleep-apnea indication.

Will my old prior authorization carry over if my employer switches to Meritain? Do not assume it will. South Orange's transition FAQ says prior approvals under its former arrangement would not carry over. Ask your new PBM about your exact Wegovy authorization and start before the next fill is due.

Is the $25 Wegovy savings offer real? Yes, for eligible patients with commercial insurance, subject to a maximum savings of $100 per month. Government beneficiaries are excluded. “As little as $25” is not a promise that every eligible claim will fall to $25.

Can I use my HSA or FSA for Wegovy? IRS Publication 969 says HSA and FSA funds can generally pay qualified medical expenses, and prescription drugs generally qualify. Save the receipt and follow your account administrator's substantiation rules.

Can I appeal a plan exclusion? Ask for your written appeal rights, but an appeal generally cannot create a benefit that the plan expressly excludes. First find out whether the problem is an exclusion, non-formulary product, failed clinical criterion, or missing document. They have different fixes.

What if my portal says covered but the pharmacy rejects it? Ask the pharmacist for the exact rejection language. Then confirm the exact product, prescribed-use benefit, prior authorization, pharmacy network, quantity, and whether the drug list changed at plan renewal.

What happens if I change jobs mid-treatment? The new employer's plan has new documents and may use a different PBM. Do not assume an old authorization or price transfers. Check the new plan before the first refill under it when possible.

Does the Medicare GLP-1 Bridge use Meritain? No. The Bridge is a separate CMS program with a central processor and its own pharmacy-first prior-authorization route. Your Meritain employer benefit and Bridge eligibility are separate questions.

What should I do in the next ten minutes?

The three facts no public website can look up for you are the exact Wegovy product on your prescription, whether your plan excludes the prescribed benefit or use, and whether prior authorization or a pharmacy rule applies. Get those three, write down the reference number, and you'll know your answer and next step.

• [ ] Get your insurance card, both sides
• [ ] Find the pharmacy number or PBM name
• [ ] Confirm the exact Wegovy form, strength, and dose on your prescription
• [ ] Search your member portal for that exact product
• [ ] Ask whether the prescribed use and weight-loss medication benefit are covered
• [ ] Ask whether prior authorization, step therapy, a program, or a restricted pharmacy applies
• [ ] Ask for the written criteria and exclusion language
• [ ] Ask what you will owe after the deductible, copay, or coinsurance
• [ ] Write down the representative's name, date, and reference number
• [ ] If it's a no, match the exact rejection to the decoder above

One health note, because it matters more than coverage: Wegovy is a prescription medication with a boxed warning about the risk of thyroid C-cell tumors. It is contraindicated for people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Coverage says nothing about whether a medication is right for your body. Read the current prescribing information and talk it through with a licensed clinician.

Still not sure which GLP-1 program is right for you? Use our free matching tool — it takes about two minutes.

Last verified: August 18, 2026. Next price check: August 31, 2026, when the current 4 mg Wegovy tablet offer is scheduled to change. We also recheck manufacturer pricing, savings terms, Medicare Bridge rules, Ro's checker scope, Meritain routing, and employer plan-year documents on a rolling schedule.